Filing Details
GRI Bio, Inc. (NASDAQ:GRI) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:GRI
GRI Bio, Inc. (GRI) Files Quarterly Report for Q0
GRI Bio, Inc. (NASDAQ:GRI) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
At publication ·
What changed
GRI Bio, Inc. (NASDAQ:GRI) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- GRI Bio, Inc. filed its quarterly report (Form 10-Q) with the SEC on August 14, 2026.
- The company's stock trades at $1.67 with a market capitalization of $1.3 million.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this summary.
Market Context
GRI Bio, Inc.'s stock currently trades at $1.67 with a market capitalization of $1.3M.
The 10-Q provides GRI Bio, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for GRI Bio, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View GRI Stock Page
Frequently Asked Questions
Where can I read GRI's SEC filings?
Browse all filings on our GRI SEC filings page.
What types of SEC filings does GRI Bio, Inc. file?
Public companies like GRI Bio, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
